Analysis in progress
Initialising…
0%
complete
This report is still being assembled — sections appear as each stage finishes. It isn't final yet.
GNA11
Final classification
VUS
GNA11 c.506_507delinsTT · p.Thr169Ile
GNA11

NM_002067.5:c.506_507delinsTT (p.Thr169Ile) in GNA11 is absent from all queried population databases (gnomAD v2.1, v4.1, gnomAD-Canada), meeting PM2_Supporting.

Gene
GNA11
Transcript
NM_002067.5
HGVS · transcript:coding
NM_002067.5:c.506_507delinsTT
Consequence
N/A
GRCh38
chr19:3114973 CC>TT
GRCh37
chr19:3114971 CC>TT
Basis gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting; combination = 1 supporting, which maps to VUS.
gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting; combination = 1 supporting, which maps to VUS.
Classification rationale
PM2 VUS
GNA11 c.506_507delinsTT

NM_002067.5:c.506_507delinsTT (p.Thr169Ile) in GNA11 is absent from all queried population databases (gnomAD v2.1, v4.1, gnomAD-Canada), meeting PM2_Supporting.1 The variant is not a null variant (nonsense, frameshift, or canonical splice site) and does not qualify for PVS1 per ClinGen SVI PVS1 recommendations (PMC6185798); it is an in-frame delins producing a single missense substitution.2 No additional pathogenic or benign criteria are met. Computational evidence (SpliceAI max delta = 0.02) does not support PP3 or BP4, and no functional, segregation, or case-level data are available. The variant is classified as a Variant of Uncertain Significance (VUS) under generic ACMG/AMP 2015 rules; PM2_Supporting alone is insufficient to reach Likely Pathogenic or Likely Benign.3

PM2 VUS
2 pvs1_generic_framework ↗pvs1_variant_assessment
3 spliceai ↗generic_acmg_combination_rules
Gene diagram · NM_002067.5 · variants mapped to exon structure
GNA11 NM_002067.5
Fetching transcript structure from UCSC…
Applied criteria · 1 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      Absent from gnomAD v4.1.
      v2.1
      Absent from gnomAD v2.1.
      🇨🇦 CA
      Absent from gnomAD-Canada v1.0.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      gnomAD v2.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      gnomAD Canada 🇨🇦
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      ClinVar screenshot
      ClinVar
      This variant is absent from ClinVar.
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.02).
      Functional / OncoKB screenshot
      Functional Unknown Oncogenic Effect
      OncoKB did not identify variant-specific reviewed functional evidence for this variant; gene-level curated context is available for reviewer follow-up. GNA11, a G protein subunit, is recurrently mutated in uveal melanoma.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Sources & reference links
      8Sources
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      gnomAD-Canada
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots